A centrifugal microfluidic cross-flow filtration platform to separate serum from whole blood for the detection of amphiphilic biomarkers

The separation of biomarkers from blood is straightforward in most molecular biology laboratories. However, separation in resource-limited settings, allowing for the successful removal of biomarkers for diagnostic applications, is not always possible. The situation is further complicated by the need...

Full description

Saved in:
Bibliographic Details
Published inScientific reports Vol. 11; no. 1; p. 5287
Main Authors Lenz, Kiersten D., Jakhar, Shailja, Chen, Jing W., Anderson, Aaron S., Purcell, Dylan C., Ishak, Mohammad O., Harris, Jennifer F., Akhadov, Leyla E., Kubicek-Sutherland, Jessica Z., Nath, Pulak, Mukundan, Harshini
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 05.03.2021
Nature Publishing Group
Nature Portfolio
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The separation of biomarkers from blood is straightforward in most molecular biology laboratories. However, separation in resource-limited settings, allowing for the successful removal of biomarkers for diagnostic applications, is not always possible. The situation is further complicated by the need to separate hydrophobic signatures such as lipids from blood. Herein, we present a microfluidic device capable of centrifugal separation of serum from blood at the point of need with a system that is compatible with biomarkers that are both hydrophilic and hydrophobic. The cross-flow filtration device separates serum from blood as efficiently as traditional methods and retains amphiphilic biomarkers in serum for detection.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Defense Threat Reduction Agency (DTRA)
LA-UR-20-25386
LDRD ER; 89233218CNA000001
USDOE Laboratory Directed Research and Development (LDRD) Program
ISSN:2045-2322
2045-2322
DOI:10.1038/s41598-021-84353-z